In focus · trending topic

NASH Cirrhosis

12 stories · following the connections

Galectin Therapeutics to Present at BIO CEO & Investor Conference

By Nasdaq OMXFeb 6, 2018, 2:15 PM UTC

Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs

By Nasdaq OMXJan 25, 2018, 1:31 PM UTC

Galectin Therapeutics to Webcast Corporate Update at Annual Meeting of Shareholders

By Nasdaq OMXDec 11, 2017, 2:00 PM UTC

Galectin Therapeutics Reports 2017 Third Quarter Financial Results and Provides Business Update

By Nasdaq OMXNov 7, 2017, 1:15 PM UTC